StockData
Fennec Pharmaceuticals Inc. logo

Fennec Pharmaceuticals Inc. (FENC) stock

FENCNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3088% above fair value
$13.33−0.25 (-1.84%)

Close on Nov 18, 2026Market cap $467.45MP/E –Yield –

Fennec Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Fennec Pharmaceuticals's total debt was $25.00M at Sep 30, 2022. For fiscal 2021 it was $5.00M.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$5.00M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2022Sep 30, 2022$25.00M–
Q2 FY2022Jun 30, 2022$5.00M–
Q1 FY2022Mar 31, 2022$5.00M–
Q4 FY2021Dec 31, 2021$5.00M–

More Fennec Pharmaceuticals figures

See a number that looks wrong?